CNTA - Centessa Pharmaceuticals Plc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - CNTA (1847903)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
37 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2023-09-20
CNTARotman HarrisSVP Regulatory AffairsS - Sale+OE$6.29-37,48433,500-53%-$235,688
2023-06-01
CNTAYver AntoineEVP, COB of DevelopmentS - Sale$4.45-6,500783,066-1%-$28,949
2023-05-24
CNTABush Tia LChief Quality OfficerS - Sale$4.48-8,000157,102-5%-$35,865
2023-05-01
CNTAYver AntoineEVP, COB of DevelopmentS - Sale$4.42-6,800789,566-1%-$30,083
2023-04-03
CNTAYver AntoineEVP, COB of DevelopmentS - Sale$3.69-6,700796,366-1%-$24,730
2023-03-01
CNTAYver AntoineEVP, COB of DevelopmentS - Sale$3.42-7,000806,681-1%-$23,970
D
2023-02-01
CNTAYver AntoineEVP, COB of DevelopmentS - Sale+OE$3.79-7,700813,681-1%-$29,201
2023-01-04
CNTAYver AntoineEVP, COB of DevelopmentS - Sale$3.18-6,970751,913-1%-$22,136
2022-12-01
CNTAYver AntoineEVP, COB of DevelopmentS - Sale$3.91-9,400761,151-1%-$36,744
A
2022-10-03
CNTAYver AntoineEVP, COB of DevelopmentS - Sale$3.91-9,5001,570,002-1%-$37,108
2022-11-01
CNTAYver AntoineEVP, COB of DevelopmentS - Sale$4.03-9,700765,059-1%-$39,055
M
2022-09-30
CNTAChao David MChief Administrative OfficerS - Sale$4.00-7,568222,932-3%-$30,293
M
2022-09-30
CNTATempleman ThomasCTOS - Sale$4.00-4,458135,792-3%-$17,844
M
2022-09-30
CNTAGrainger David JChief Innovation OfficerS - Sale$4.00-5,181936,075-1%-$20,739
M
2022-09-30
CNTAWeinhoff Gregory MCFOS - Sale$4.00-8,901231,099-4%-$35,629
M
2022-09-30
CNTAYver AntoineEVP, COB of DevelopmentS - Sale$3.94-14,992774,759-2%-$59,091
M
2022-09-30
CNTAHussain Iqbal JGCS - Sale$4.00-8,288160,212-5%-$33,175
M
2022-09-30
CNTAShahidi JavadChief Medical OfficerS - Sale$4.00-6,068158,932-4%-$24,289
M
2022-09-30
CNTABush Tia LChief Quality OfficerS - Sale$4.00-4,713143,287-3%-$18,865
2022-09-01
CNTAYver AntoineEVP, COB of DevelopmentS - Sale$4.41-10,423789,751-1%-$45,987
2022-08-01
CNTAYver AntoineEVP, COB of DevelopmentS - Sale$4.45-10,423800,174-1%-$46,405
2022-07-18
CNTAYver AntoineEVP, COB of DevelopmentS - Sale$4.87-20,000810,597-2%-$97,312
2022-07-01
CNTAYver AntoineEVP, COB of DevelopmentS - Sale$5.03-9,100830,597-1%-$45,797
2022-06-24
CNTASaha SaurabhCEOP - Purchase$4.63+10,00038,000+36%+$46,284
2022-06-17
CNTAYver AntoineEVP, COB of DevelopmentS - Sale$4.68-9,200739,697-1%-$43,036
M
2022-05-17
CNTAYver AntoineEVP, COB of DevelopmentS - Sale$5.17-85,000748,897-10%-$439,734
2022-02-02
CNTASaha SaurabhCEOP - Purchase$9.74+5,00028,000+22%+$48,700
2022-01-28
CNTAGrainger David JChief Innovation OfficerP - Purchase$9.05+27,500841,256+3%+$248,754
2021-12-02
CNTADe Rubertis FrancescoDirP - Purchase$12.82+34,32614,186,9220%+$440,059
2021-12-02
CNTAMedicxi Ventures Management (Jersey) Ltd10%P - Purchase$12.82+34,32614,186,9220%+$440,059
M
2021-11-30
CNTADe Rubertis FrancescoDirP - Purchase$12.24+97,15114,186,126+1%+$1,189,199
M
2021-11-30
CNTAMedicxi Ventures Management (Jersey) Ltd10%P - Purchase$12.24+97,15114,186,126+1%+$1,189,199
M
2021-11-26
CNTADe Rubertis FrancescoDirP - Purchase$11.64+68,52314,183,8720%+$797,426
M
2021-11-26
CNTAMedicxi Ventures Management (Jersey) Ltd10%P - Purchase$11.64+68,52314,183,8720%+$797,426
2021-11-18
CNTAKantoff AaronDirP - Purchase$11.99+10,00060,000+20%+$119,850
2021-11-16
CNTASaha SaurabhCEOP - Purchase$12.28+23,00023,000New+$282,472
2021-11-16
CNTABush Tia LChief Quality OfficerP - Purchase$12.46+5,0008,000+167%+$62,302

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top